Understanding hypoxia signalling in cells – a new therapeutic opportunity?

Abstract
The possibility that cells possess specific interfaces with molecular oxygen that have a prime function in biological control has long interested biologists. Specific ‘oxygen-sensing’ mechanisms have been defined in bacteria and yeast, but, until recently, have remained elusive in higher organisms. Studies of hypoxia pathways have now, however, revealed the existence of a series of non-haem Fe(II) and 2-oxoglutarate-dependent dioxygenases that catalyse oxygen-regulated hydroxylation of specific amino acids in a key transcription factor termed hypoxia-inducible factors (HIFs). These post-translational hydroxylations govern both the proteolytic stability and activity of HIF and therefore the transcription of many hundreds of human genes whose expression changes in accordance with cellular oxygen availability. This paper will review these developments and consider the biological and potential therapeutic implications.
- © 2006 Royal College of Physicians
Article Tools
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy
- Hypoxia-Mediated Induction of the Polyamine System Provides Opportunities for Tumor Growth Inhibition by Combined Targeting of Vascular Endothelial Growth Factor and Ornithine Decarboxylase
- The Active Site of an Algal Prolyl 4-Hydroxylase Has a Large Structural Plasticity
- Hypoxia-inducible Factor-1 Mediates Neuronal Expression of the Receptor for Advanced Glycation End Products following Hypoxia/Ischemia
- A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove